Mike Gladstone, global president and general manager of Pfizer Inflammation and Immunology unit, said that the acquisition of Arena is in line with the company’s capabilities and expertise in immunology and inflammatory-related conditions. Over the years, Pfizer has successfully created an innovation engine that develops potential medicines for patients worldwide with chronic and debilitating immuno-inflammatory conditions. The company understands that there is an urgent need to look into other treatment options with high potential, which is where Arena’s cannabinoid-drug pipeline comes in.
The industry’s attention still gravitates toward the legacy states. But through operators like SWADE Cannabis…
Metro Boomin and Action Bronson are headlining Puffcon in October, and that alone is worth…
Mary Jane Berlin brought tens of thousands of people into one building and reminded them…
Sacha Baron Cohen has reportedly been filming a new Ali G movie in secret. Could…
Big news for wellness enthusiasts: Canna River, the family-run brand that’s spent years earning trust…
Let's start with the headline nobody in Washington wants to print: marijuana is still illegal.…